A practical reference on cyclic heptapeptide: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
Research interest has centred on photoprotection and pigmentation, with a smaller body of work on appetite and sexual function. Published human data remain limited to small, frequently uncontrolled studies, and the compound has never received marketing approval from a national medicines regulator. Most laboratory work treats it as a pharmacological tool for probing melanocortin signalling in cell culture or animal models. Whether pigmentation changes observed in people translate into measurable protection against ultraviolet-induced DNA damage remains an open question.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, the naturally occurring peptide involved in pigmentation signalling. Its sequence is conventionally written as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, with a lactam bridge joining the aspartate side chain to the lysine side chain. The empirical formula is C50H69N15O9 and the monoisotopic mass lies near 1023.5 daltons. N-terminal acetylation and the D-configured phenylalanine both increase resistance to enzymatic breakdown compared with the parent hormone.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | Melanotan II; MT-II; N-acetyl-norleucyl-cyclo[Asp-His-D-Phe-Arg-Trp-Lys] amide | Naming follows peptide convention; the numeral distinguishes it from melanotan-1 |
| Molecular formula | C50H69N15O9 | Includes the lactam bridge; no counter-ion assumed |
| Monoisotopic mass | 1023.53 Da | Free base; salts and counter-ions shift the observed value |
| Appearance | White to off-white lyophilised powder | Batch-to-batch colour variation is not itself proof of impurity |
| Typical analytical method | RP-HPLC purity determination with ESI-MS identity confirmation | Retention time alone does not establish sequence identity |
The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.
Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.
Melanotan II is a synthetic peptide analog modeled on alpha-melanocyte-stimulating hormone, a naturally occurring signaling peptide involved in pigmentation. Its structure is a cyclic heptapeptide containing two non-natural substitutions, norleucine at position four and D-phenylalanine at position seven. These modifications resist enzymatic breakdown and extend the molecule's activity relative to the native hormone. The compound binds melanocortin receptors and is studied mainly as a pharmacological tool rather than a therapeutic product. It has never received approval as a medicine in any major jurisdiction.
Published human data come mostly from small, short studies rather than large controlled trials. Reported outcomes include increased skin pigmentation and, in some reports, effects on appetite and libido, but sample sizes are small and follow-up is limited. Whether long-term use produces durable pigment changes or adverse effects is not established. Because products sold outside pharmacies are not standardized, the actual content of any given vial is often unknown. Independent testing of such material is uncommon.
Melanotan II is a synthetic cyclic heptapeptide analog derived from the core sequence of alpha-melanocyte-stimulating hormone. Researchers at the University of Arizona synthesized it during the 1980s while studying pigmentation and appetite signaling. The compound is not an approved medicine in any major jurisdiction and appears mainly in laboratory and research-chemical settings. Its structure incorporates a lactam bridge between side chains, which constrains the ring and slows enzymatic breakdown relative to the natural hormone.
The compound emerged from research programs in the 1980s that examined analogues of alpha-melanocyte-stimulating hormone for pigmentation and photoprotection. Investigators modified the native sequence to extend activity duration and potency. A related analogue, afamelanotide, was developed within the same broad line of inquiry and eventually gained approval in certain jurisdictions for a rare light-sensitivity condition. Melanotan-2 itself did not progress through the same regulatory route and has no approved therapeutic indication.
Melanocortin receptors comprise five subtypes with distinct tissue distributions and functions. Melanotan-2 is described in the literature as a non-selective agonist that engages several of these subtypes, including MC1R, MC3R, MC4R, and MC5R. MC1R is the subtype most directly linked to melanin production in skin cells. Because the compound is not subtype-selective, its observed effects in experimental settings are generally attributed to activity across multiple receptor pathways rather than to a single target.
=== France === The soybean was first cultivated in France by 1779 (and perhaps as early as 1740). The two key early people and organizations introducing the soybean to France were the Society of Acclimatization (starting in 1855) and Li Yu-ying (from 1910). Li started a large tofu factory, where the first commercial soyfoods in France were made.
acid 1. (Brønsted–Lowry acid) Any chemical species or molecular entity that acts as a proton donor when reacting with another species, because it loses at least one proton (H+) which is then transferred or 'donated' to the other species, which by definition is a Brønsted–Lowry base. When dissolved in an aqueous solution, a proton donor which increases the concentration of hydronium ion (H3O+) by transferring protons to water molecules may also be called an Arrhenius acid. The term "acid", when not otherwise qualified, often refers implicitly to a Brønsted–Lowry acid. 2. (Lewis acid) Any chemical species or molecular entity that acts as an electron pair acceptor when reacting with another species, forming a covalent bond by accepting a lone pair of electrons donated by the other species, which is known as a Lewis base. This definition was intended as a generalization of the Brønsted–Lowry definition by proposing that acid-base reactions are best viewed as reorganizations of electrons rather than transfers of protons, with the acid being a species that accepts electron pairs from another species either directly or by releasing protons (H+) into the solution, which then accept electron pairs from the other species. The Lewis definition is inclusive of many Brønsted–Lowry acids, though not all: most Lewis acids are not Brønsted–Lowry acids, and most Brønsted–Lowry acids are not Lewis acids. 3. Colloquially, any compound which, when dissolved in water, yields a pH of less than 7.0.
Graham Thomas Waters. Founder and Managing Director, Airbond. For services to Innovation. Selina Marie Webb. Executive Vice President, Universal Music UK. For services to the Music Industry, to Neurodiversity and to Charity. Maurice Scott Weightman. Founding Chair and Trustee, Berwick Youth Project. For services to Young People in Berwick-Upon-Tweed. Arabella Helen Weir. Artistic Director, Kirkcaldy Festival of Ideas and Trustee, Theirworld Children's Charity. For services to the Arts and to Young People. James Michael Whale. Broadcaster. For services to Broadcasting and to Charity. Anne Patricia White. Volunteer Director, Thurrock Lifestyle Solutions Community Interest Company. For services to People with Impairments. Jonathan Richard White. Economist, Department of Health and Social Care. For services to Social Care Policy. Claire Amanda Whiting. Founder, Two2One. For services to Bereaved People in Southend-on-Sea, Essex. Carly Ann Whyborn. Director, Refugees at Home. For services to Refugees. Carla Maria Williams (Carla Marie Williams). Chief Executive Officer and Founder, Girls I Rate and Songwriter. For services to Music. Dr. Elizabeth Catherine Williams (Kay Williams). Head of International Chemicals, Pesticide and Hazardous Waste, Department for Environment, Food and Rural Affairs. For services to the International Environment and charitable service through Bees Abroad. Gareth David Williams. Detective Superintendent, British Transport Police. For services to Policing. Joanne Kate Williams (Kate Woolveridge). Chief Executive Officer, Forget-me-not Chorus.
== Research == Quadrupole theory (stability, acceptance and transmission of multipole RF and electrostatic driven devises), molecular gas dynamics, and supersonic beam expansion into vacuum. Development of the DRC Collision/reaction cell. Development of mass spectrometry (CyTOF), including fundamentals of operation and design of different MS instrumentation.
In the 1990s, the groups that continued to research cold fusion and their supporters established (non-peer-reviewed) periodicals such as Fusion Facts, Cold Fusion Magazine, Infinite Energy Magazine and New Energy Times to cover developments in cold fusion and other fringe claims in energy production that were ignored in other venues. The internet has also become a major means of communication and self-publication for CF researchers.
Sources: en.wikipedia.org
The material to be dried is placed on a conveyor belt made of an infrared-transparent plastic, such as Mylar. The conveyor belt covers a reservoir of heated water. Where moist material contacts the Mylar film, an 'infrared window' is created. This allows infrared light to pass from the hot water to the moist material. Since the window requires moisture, it closes as the material dries, limiting the temperature to about 75°C. RWD boasts the use of three modes of heat transfer (convection in the water, conduction through the conveyor belt and radiation through the Mylar).
He had to leave the game after the seventh with a pulled back muscle, but he was back in action four days later. He won just twice more all season, as he dealt with back problems. On August 1, he again struck out eight Phillies but received a no decision, as he was removed with one out in the ninth and the game tied 1–1. The Cardinals won on a Stan Musial home run in the bottom of the inning. In 31 games (30 starts), he had a 13–10 record, a 4.20 ERA, 108 strikeouts, and 89 walks in 201+1⁄3 innings pitched. By 1960, Mizell had recovered from his back issues. He began the season with the Cardinals but only won one of his first nine games, posting a 4.55 ERA. By this point, the Cardinals felt that he had never attained his full potential. On May 28, they traded him and Dick Gray to the Pirates for Ed Bauta and Julián Javier, the latter of whom would reach two All-Star Games and win two World Series with the Cardinals over the next decade.
==== Offender rehabilitation ==== Traditional work with offenders has focused on their deficits (e.g., with respect to socialization, and schooling) and other "criminogenic" risk-factors. Rehabilitation more often than not has taken the form of forced treatment or training, ostensibly for the good of the offender, and the community. Arguably, this approach has shortcomings, suggesting a need to make available additional positive options to treatment staff so they can best assist offenders, and so that offenders can better find their way forward. Positive psychology has made recent inroads with the advent of the "Good Lives Model", developed by Tony Ward, Shadd Maruna, and others. With respect to rehabilitation: "Individuals take part ... because they think that such activities might either improve the quality of their life (an intrinsic goal) or at least look good to judges, parole boards and family members (an extrinsic goal)."
Many species, varieties and cultivars are grown in gardens for their ornamental flowers. In horticulture the term pansy is normally used for those multi-colored, large-flowered cultivars which are raised annually or biennially from seed and used extensively in bedding. The terms viola and violet are normally reserved for small-flowered annuals or perennials, including the wild species. Cultivars of Viola cornuta, Viola cucullata, and Viola odorata, are commonly grown from seed. Other species often grown include Viola labradorica, Viola pedata, and Viola rotundifolia. The modern garden pansy (V. × wittrockiana) is a plant of complex hybrid origin involving at least three species, V. tricolor (wild pansy or heartsease), V. altaica, and V. lutea (mountain pansy). The hybrid horned pansy (V. × williamsii) originates from hybridization involving garden pansy and Viola cornuta.
Sources: en.wikipedia.org
British, French, German, and other governments were forced to turn some banks into partially or wholly state-owned banks. Some governments instead guaranteed their banks' debts. In turn, the European debt crisis developed when international investment withdrew and Greece, Spain, Portugal, and Ireland saw international bond markets charge unsustainably high interest rates on government debt. Eurozone governments and staff of the European Central Bank believed that it was necessary to save their banks by taking over Greek debt, and impose "austerity" and "structural adjustment" measures on debtor states. This exacerbated further contraction in the economies. In 2011 two new treaties, the European Fiscal Compact and European Stability Mechanism were signed among the nineteen Eurozone states. In 2013, Croatia entered the union. However a further crisis was triggered after the UK's Conservative government chose to hold a referendum in 2016, and campaigners for "leave" (or "Brexit") won 51.89 per cent of votes on a 72.2 per cent turnout. This referendum was politically inconclusive given the UK's system of Parliamentary sovereignty, with no agreement after the 2017 election, until the 2019 general election brought a Conservative majority with a manifesto commitment to drive through Brexit. The UK left EU membership in February 2020, with uncertain economic, territorial and social consequences.
On 20 January, the Brazilian Ministry of Health declared a national emergency following reports of deaths among Yamomami children due to malnutrition and easily curable diseases. The president of the FUNAI also led the creation of a task force to deal with the humanitarian crisis. Between 2019 and 2023, at least of 570 Yanomami children died from malnutrition, hunger and mercury contamination. Lula accused Jair Bolsonaro's government of having committed genocide against the Yanomami, several researchers blamed the entry of illegal miners into protected native lands for the high amount of deaths between the local indigenous peoples, as well as alleged connivance and omission of the federal and local/state administrations during the previous government. Due to the high number of deaths since 2023, reports on the situation decreased, until they stopped being published at the beginning of 2024, when there was a further increase in deaths due to violence.
Oxytocin+receptor at the U.S. National Library of Medicine Medical Subject Headings (MeSH) "Symbol Report: OXTR". HUGO Gene Nomenclature Committee. "Vasopressin and Oxytocin Receptors: OT". The International Union of Basic and Clinical Pharmacology, The British Pharmacological Society, The University of Edinburgh. International Union of Basic and Clinical Pharmacology. This article incorporates text from the United States National Library of Medicine, which is in the public domain.
== Overview == Smoking most commonly leads to diseases affecting the heart and lungs and will commonly affect areas such as hands or feet. First signs of smoking-related health issues often show up as numbness in the extremities, with smoking being a major risk factor for heart attacks, chronic obstructive pulmonary disease (COPD), emphysema, and cancer, particularly lung cancer, cancers of the larynx and mouth, and pancreatic cancer. The immune system is also weakened by smoking, which makes the body more susceptible to infections and takes longer to recover from injuries. Overall life expectancy is also reduced in long term smokers, with estimates ranging from 10 to 17.9 years fewer than non-smokers. About half of men who smoke long-term will die of illness due to smoking. The association of smoking with lung cancer and COPD is among the strongest, both in the public perception and etiologically. Among male smokers, the lifetime risk of developing lung cancer is 17%; among female smokers, the risk is 12%. This risk is significantly lower in non-smokers: 1.3% in men and 1.4% in women. For COPD, the 25 year incidence of moderate and severe COPD is at least 21% for continuous smokers and 4% for non-smokers, with no difference being reported between men and women. A person's increased risk of contracting disease is related to the length of time that a person continues to smoke as well as the amount smoked. However, even smoking one cigarette a day raises the risk of coronary heart disease by about 50% or more, and for stroke by about 30%.
A point mutation is a genetic mutation where a single nucleotide base is changed, inserted or deleted from a DNA or RNA sequence of an organism's genome. Point mutations have a variety of effects on the downstream protein product—consequences that are moderately predictable based upon the specifics of the mutation. These consequences can range from no effect (e.g. synonymous mutations) to deleterious effects (e.g. frameshift mutations), with regard to protein production, composition, and function.
Sources: en.wikipedia.org
It is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, containing seven amino acids with a lactam ring and a D-configured phenylalanine residue. It is supplied as a lyophilised powder for laboratory research.
The natural hormone is a linear tridecapeptide that is rapidly degraded in circulation. Melanotan-2 is shortened, cyclised, N-terminally acetylated, and carries a D-amino acid substitution, all of which slow enzymatic breakdown.
No national medicines regulator has approved melanotan-2 for therapeutic or cosmetic use. In several jurisdictions it is treated as an unapproved prescription medicine, and its legal classification differs from country to country.
It is a synthetic seven-amino-acid peptide modeled on alpha-melanocyte-stimulating hormone. It carries two non-natural substitutions and a cyclic bridge that increase its stability relative to the natural hormone. It circulates as a research chemical and is not an approved medicine.